BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8160574)

  • 1. Innovations in pulse generators and lead systems: balancing complexity with clinical benefit and long-term results.
    Saksena S; Krol RB; Kaushik RR
    Am Heart J; 1994 Apr; 127(4 Pt 2):1010-21. PubMed ID: 8160574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G
    Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technologic advances in implantable cardioverter defibrillators.
    Swygman CA; Homoud MK; Link MS; Wang PJ; Estes NA
    Curr Opin Cardiol; 1999 Jan; 14(1):9-14. PubMed ID: 9932202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location.
    Saksena S; DeGroot P; Krol RB; Raju R; Mathew P; Mehra R
    Circulation; 1993 Dec; 88(6):2655-60. PubMed ID: 8252676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
    Estes NA; Haugh CJ; Wang PJ; Manolis AS
    Am Heart J; 1994 Apr; 127(4 Pt 2):1038-46. PubMed ID: 8160578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third- and fourth-generation implantable cardioverter defibrillators: current status and future development.
    Saksena S; Diaz ML; Varanasi S; Mathew P; Berg J; Krol RB; Kaushik RR
    J Interv Cardiol; 1994 Oct; 7(5):427-40. PubMed ID: 10155192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds.
    Kudenchuk PJ; Poole JE; Dolack GL; Gleva MJ; Anderson J; Troutman C; Bardy GH
    J Cardiovasc Electrophysiol; 1997 May; 8(5):485-95. PubMed ID: 9160224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations and late complications of third-generation automatic cardioverter-defibrillators.
    Nunain SO; Roelke M; Trouton T; Osswald S; Kim YH; Sosa-Suarez G; Brooks DR; McGovern B; Guy M; Torchiana DF
    Circulation; 1995 Apr; 91(8):2204-13. PubMed ID: 7697850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system.
    Saksena S; Luceri R; Krol RB; Brownstein S; Burkhardt E; Accorti P; Brewer G; Scott S; Callaghan F; Livingston A
    Am J Cardiol; 1993 Apr; 71(10):834-41. PubMed ID: 8456763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.
    Friedman PA; Bradley D; Koestler C; Slusser J; Hodge D; Bailey K; Kusumoto F; Munger TM; Militanu A; Glikson M
    Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardiac defibrillators.
    Peters RW; Gold MR
    Med Clin North Am; 2001 Mar; 85(2):343-67, xi. PubMed ID: 11233952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing.
    Plewan A; Valina C; Herrmann R; Alt E
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):228-32. PubMed ID: 9990636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of biphasic waveform pulse on endocardial defibrillation efficacy in humans.
    Neuzner J; Pitschner HF; Huth C; Schlepper M
    Pacing Clin Electrophysiol; 1994 Feb; 17(2):207-12. PubMed ID: 7513406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].
    Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W
    Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New technologies of internal defibrillation.
    Dosdall DJ; Ideker RE
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():67-70. PubMed ID: 16133858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.